Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance in Escherichia coli Associated with Urinary Tract Infections and in Commensal Strains
Restricted accessResearch articleFirst published online November, 2025
Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance in Escherichia coli Associated with Urinary Tract Infections and in Commensal Strains
Escherichia coli is a genetically versatile organism capable of thriving in diverse environments, acting as a commensal in the intestine or as a pathogen in the urinary tract. E. coli causing urinary tract infections has acquired genes that enable it to colonize the urinary tract, survive immune response, and resist antimicrobials. In this study, we investigated the association between the ESBL (Extended Spectrum Beta Lactamase) phenotype and other antimicrobial resistances in E. coli associated with urinary tract infections (UTI-E. coli; n = 1,139) and compared them with commensal E. coli strains (n = 405) isolated from human fecal samples in the same communities and during the same period. Among UTI-E. coli strains, 16.9% were ESBL producers compared to 7.6% in commensal strains, and resistance to other antimicrobials was also significantly higher in UTI-E. coli. These results suggest that many UTI-E. coli and commensal E. coli lineages have been subjected to distinct antimicrobial pressures over time.
WhelanS, LuceyB, FinnK. Uropathogenic Escherichia coli (UPEC)-Associated urinary tract infections: The molecular basis for challenges to effective treatment. Microorg, 2023; 11(9):2169; doi: 10.3390/MICROORGANISMS11092169
2.
MorenoE, JohnsonJR, PérezT, et al.Structure and urovirulence characteristics of the fecal Escherichia coli population among healthy women. Microbes Infect, 2009; 11(2):274–280.
3.
SpurbeckRR, DinhPCJr, WalkST, et al.Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract. Infect Immun, 2012; 80(12):4115–4122.
4.
MessererM, FischerW, SchubertS. Investigation of horizontal gene transfer of pathogenicity islands in Escherichia coli using next-generation sequencing. PLoS One, 2017; 12(7):e0179880.
5.
BiggelM, XavierBB, JohnsonJR, et al.Horizontally acquired papGII-containing pathogenicity islands underlie the emergence of invasive uropathogenic Escherichia coli lineages. Nat Commun, 2020; 11(1):5968.
6.
RezatofighiSE, MirzaraziM, SalehiM. Virulence genes and phylogenetic groups of uropathogenic Escherichia coli isolates from patients with urinary tract infection and uninfected control subjects: A case-control study. BMC Infect Dis, 2021; 21(1):361.
7.
NielsenKL, SteggerM, KiilK, et al.Whole-genome comparison of urinary pathogenic Escherichia coli and faecal isolates of UTI patients and healthy controls. Int J Med Microbiol, 2017; 307(8):497–507; doi: 10.1016/j.ijmm.2017.09.007
8.
RoyerG, ClermontO, MarinJ, et al.Epistatic interactions between the high pathogenicity island and other iron uptake systems shape Escherichia coli extra-intestinal virulence. Nat Commun, 2023; 14(1):3667.
9.
LiuCM, AzizM, ParkDE, et al.Using source-associated mobile genetic elements to identify zoonotic extraintestinal E. coli infections. One Health, 2023; 16:100518.
10.
KolárM, UrbánekK, LátalT. Antibiotic selective pressure and development of bacterial resistance. Int J Antimicrob Agents, 2001; 17(5):357–363.
11.
KaramMRA, HabibiM, BouzariS. Relationships between virulence factors and antimicrobial resistance among Escherichia coli Isolated from urinary tract infections and commensal isolates in Tehran, Iran. Osong Public Health Res Perspect, 2018; 9(5):217–224; doi: 10.24171/j.phrp.2018.9.5.02
12.
BiggelM, MoonsP, NguyenMN, et al.Convergence of virulence and antimicrobial resistance in increasingly prevalent Escherichia coli ST131 papGII+ sublineages. Commun Biol, 2022; 5(1):752; doi: 10.1038/s42003-022-03660-x
13.
LoayzaF, GrahamJP, TruebaG. Factors obscuring the role of E. coli from domestic animals in the global antimicrobial resistance crisis: An evidence-based review. Int J Environ Res Public Health, 2020; 17(9):3061; doi: 10.3390/IJERPH17093061
14.
VanderYachtT, SalinasL, RemerleitchT, et al.Lack of wastewater treatment in a small town drives the spread of ESBL-producing Escherichia coli in irrigation waters. J Environ Qual, 2024; 53(6):1116–1126.
15.
KouriTT, HofmannW, FalboR, et al.; European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). The EFLM European Urinalysis Guideline 2023. Clin Chem Lab Med, 2024; 62(9):1653–1786.
16.
CalderónD, CárdenasPA, Prado-VivarB, et al.A longitudinal study of dominant E. coli lineages and antimicrobial resistance in the gut of children living in an upper middle-income country. J Glob Antimicrob Resist, 2022; 29:136–140; doi: 10.1016/j.jgar.2022.03.002
17.
Clinical and Laboratory Standards Institute (CLSI). Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data. 5th ed. CLSI guideline M39. CLSI: Wayne, PA; 2022.
18.
QinX, HuF, WuS, et al.Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and Intestinal Commensal Escherichia coli strains. PLoS One, 2013; 8(4):e61169; doi: 10.1371/JOURNAL.PONE.0061169
19.
CritchleyIA, CotroneoN, PucciMJ, et al.The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PLoS One, 2019; 14(12):e0220265; doi: 10.1371/JOURNAL.PONE.0220265
20.
KimDD, SwarthoutJM, WorbyCJ, et al.Contaminated drinking water facilitates Escherichia coli strain-sharing within households in urban informal settlements. Nat Microbiol, 2025; 10(5):1198–1209.
21.
DenamurE, ClermontO, BonacorsiS, et al.The population genetics of pathogenic Escherichia coli. Nat Rev Microbiol, 2021; 19(1):37–54; doi: 10.1038/s41579-020-0416-x
22.
van DrielAA, NotermansDW, MeimaA, et al.Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis, 2019; 38(11):2151–2158.
23.
ChastreJ, WolffM, FagonJ-Y, et al.; PneumA Trial Group. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA, 2003; 290(19):2588–2598.
24.
SánchezX, LatacungaA, CárdenasI, et al.Antibiotic prescription patterns in patients with suspected urinary tract infections in Ecuador. PLoS One, 2023; 18(11):e0295247; doi: 10.1371/journal.pone.0295247
25.
LeeDS, LeeSJ, ChoeHS. Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. Biomed Res Int, 2018; 2018:7656752; doi: 10.1155/2018/7656752
